Suenaga, Mitsukuni http://orcid.org/0000-0002-6634-2893
Schirripa, Marta
Cao, Shu
Zhang, Wu
Cremolini, Chiara
Lonardi, Sara http://orcid.org/0000-0002-7593-8138
Okazaki, Satoshi
Berger, Martin D.
Miyamoto, Yuji
Soni, Shivani
Barzi, Afsaneh
Yamaguchi, Toshiharu
Loupakis, Fotios
Falcone, Alfredo
Lenz, Heinz-Josef http://orcid.org/0000-0003-2178-9568
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA014089)
Article History
Received: 8 May 2020
Revised: 26 November 2020
Accepted: 15 January 2021
First Online: 4 February 2021
Compliance with ethical standards
:
: All authors have read the journal’s policy on disclosure of potential conflicts of interest. CC is a consultant/advisory board member for Roche, Amgen, Bayer, Merck Serono, Servier. AF is a consultant/advisory board member for Bayer, Roche, Amgen, Eli-Lilly, Merck Serono, Bristol-Myers Squibb, Sanofi, and Servier. H-JL is consultant /advisory board member for Bristol-Myers Squibb, Merck Serono, and Bayer. All remaining authors have no conflicts of interest to declare in this work.